VINEETLAB

Vineet Laboratories Share Price

 

 

Start SIP in VINEETLAB

Start SIP

Performance

  • Low
  • ₹34
  • High
  • ₹35
  • 52 Week Low
  • ₹22
  • 52 Week High
  • ₹52
  • Open Price₹34
  • Previous Close₹34
  • Volume10,112
  • 50 DMA₹35.52
  • 100 DMA₹34.26
  • 200 DMA₹34.16

Investment Returns

  • Over 1 Month -3.77%
  • Over 3 Month + 1.58%
  • Over 6 Month + 21.13%
  • Over 1 Year -30.59%

Smart Investing Starts Here Start SIP with Vineet Laboratories for Steady Growth!

Invest Now

Vineet Laboratories Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • -3.9
  • PEG Ratio
  • 0
  • Market Cap Cr
  • 65
  • P/B Ratio
  • 1.5
  • Average True Range
  • 1.92
  • EPS
  • 0
  • Dividend Yield
  • 0
  • MACD Signal
  • 0.06
  • RSI
  • 39.6
  • MFI
  • 51.36

Vineet Laboratories Financials

Vineet Laboratories Technicals

EMA & SMA

Current Price
₹33.99
+ 0.43 (1.28%)
pointer
  • Bearish Moving Average 13
  • Bullish Moving Average 3
  • 20 Day
  • ₹35.78
  • 50 Day
  • ₹35.52
  • 100 Day
  • ₹34.26
  • 200 Day
  • ₹34.16

Resistance and Support

34.01 Pivot Speed
  • R3 37.21
  • R2 36.29
  • R1 34.93
  • S1 32.65
  • S2 31.73
  • S3 30.37

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Vineet Laboratories has an operating revenue of Rs. 57.04 Cr. on a trailing 12-month basis. An annual revenue de-growth of -49% needs improvement, Pre-tax margin of -28% needs improvement, ROE of -137% is poor and needs improvement. The company has a reasonable debt to equity of 26%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its 50DMA and around 14% up from its 200DMA. It needs to take out the 50DMA levels and stay above it to make any further meaningful move. It is currently FORMING a base in its weekly chart and is trading around 20% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 52 which is a POOR score indicating inconsistency in earnings, a RS Rating of 61 which is FAIR indicating the recent price performance, Buyer Demand at D which indicates heavy supply, Group Rank of 71 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of C is fair but needs to improve. Overall, the stock has mediocre technical strength and poor fundamentals, there are superior stocks in the current market environment.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Vineet Laboratories Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-11-27 Right issue of Equity Shares
2025-11-08 Quarterly Results
2025-07-22 Quarterly Results
2025-05-12 Audited Results
2025-02-12 Quarterly Results
Date Purpose Remarks
2022-09-20 FINAL Rs.1.00 per share(10%)Final Dividend
View Vineet Laboratories Dividend History Arrow

Vineet Laboratories F&O

Vineet Laboratories Shareholding Pattern

15.89%
78.17%
5.94%

About Vineet Laboratories

  • NSE Symbol
  • VINEETLAB
  • BSE Symbol
  • 543298
  • Managing Director
  • Mr. Gaddam Venkata Ramana
  • ISIN
  • INE505Y01010

Similar Stocks to Vineet Laboratories

Vineet Laboratories FAQs

Vineet Laboratories share price is ₹33 As on 08 January, 2026 | 10:51

The Market Cap of Vineet Laboratories is ₹65.3 Cr As on 08 January, 2026 | 10:51

The P/E ratio of Vineet Laboratories is -3.9 As on 08 January, 2026 | 10:51

The PB ratio of Vineet Laboratories is 1.5 As on 08 January, 2026 | 10:51

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23